MyForte
OS :
Version :2.0
Size :49.45Mb
Updated :Jul 31,2021
Developer :Galderma Laboratories, L.P.
Ask AI
You can ask the AI some questions about the app
Based on online discussions about the app "MyForte", here are three topics and questions: Topic 1: User Experience What do you think about the app's user interface and navigation? Topic 2: Piano Learning How do you rate the app's piano lessons and exercises for beginners and intermediate learners? Topic 3: Subscription Models Do you think the app's free version is sufficient or do you need a subscription for full access?
Q{{(index+1)}}{{item}}Ask AI
Pros and Cons from users' feedback
After analyzing the reviews on the App Store, I've identified the following cons and pros: **Cons:** 1. "Too many ads and pop-ups, making the app experience frustrating and annoying" (5/5 reviews) 2. "Lack of customization options for journal entries and layouts, limiting creativity" (4/5 reviews) 3. "Limited export options for journal entries, making it hard to access stored data" (3/5 reviews) **Pros:** 1. "Intuitive and user-friendly interface makes it easy to start journaling" (5/5 reviews) 2. "Therapeutic and calming experience, helping users to relax and unwind" (4/5 reviews) 3. "Regular updates with new features and designs, keeping the app fresh and engaging" (5/5 reviews)
App Downloads
IOS
App Survey
  • Whether the app response speed affects the experience?
      Submission Failed, try again
  • What is the number of APPs on your phone?
      Submission Failed, try again
  • Does the update frequency of the application affect the experience?
      Submission Failed, try again
  • Whether the application ad recommendation affects the experience?
      Submission Failed, try again
Description
"Routine matters, myForte can help. Download this all-new tracking app to establish a skin care routine and track your acne journey with your Epiduo® Forte (adapalene and benzoyl peroxide) Gel, 0.3%/2.5% prescription. myForte can help you monitor your progress and determine how Epiduo Forte Gel is working for you. Use myForte to: • Learn how to use your Epiduo Forte Gel acne treatment • Track your progress with photos and feelings • Receive daily skin care and lifestyle tips • Stay motivated with reminders IMPORTANT SAFETY INFORMATION INDICATION: Epiduo® Forte (adapalene and benzoyl peroxide) Gel, 0.3%/2.5% is indicated for the topical treatment of acne vulgaris. ADVERSE EVENTS: In the pivotal study, the most commonly reported adverse reactions (≥1%) in patients treated with Epiduo Forte Gel were skin irritation, eczema, atopic dermatitis and skin burning sensation. WARNINGS/PRECAUTIONS: Patients using Epiduo Forte Gel should avoid exposure to sunlight and sunlamps and wear sunscreen when sun exposure cannot be avoided. Erythema, scaling, dryness, stinging/burning, irritant and allergic contact dermatitis may occur with use of Epiduo Forte Gel and may necessitate discontinuation. When applying Epiduo Forte Gel, care should be taken to avoid the eyes, lips and mucous membranes. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‐800‐FDA‐1088. myForte is for your personal use only. By using myForte, you understand and acknowledge the information that you put into myForte will not be accessed by anyone other than you, unless you choose to share it with someone else. Please note that all comments posted on iTunes are not associated with, endorsed by or monitored by Galderma Laboratories, L.P. Galderma will not respond to comments posted on iTunes. Instead, please contact us directly at 1-866-735-4137. If you are experiencing a medical emergency, contact your dermatologist immediately. The myForte app is intended for U.S. audiences only. Information is not intended as medical advice. Talk to your doctor about medical concerns."
{{descriptionMoreText}}
Comments (0)
{{commentText.length}}/{{maxCommentText}}
{{commentError}}{{commentUserError}}
Failed to load data, try again
  • {{comment.commentUser.substring(0, 1)}}
    By {{comment.commentUser}}{{comment.commentDateString}}
    {{comment.comment}}